IMMUTEP Ltd Files Form 6-K

Ticker: PRRUF · Form: 6-K · Filed: May 16, 2024 · CIK: 1506184

Immutep Ltd 6-K Filing Summary
FieldDetail
CompanyImmutep Ltd (PRRUF)
Form Type6-K
Filed DateMay 16, 2024
Risk Levellow
Pages1
Reading Time1 min
Sentimentneutral

Sentiment: neutral

Topics: sec-filing, 6-K, company-update

TL;DR

IMMUTEP Ltd (formerly Prima BioMed) filed a 6-K on 5/15/24. Standard update.

AI Summary

On May 15, 2024, IMMUTEP Ltd filed a Form 6-K. The company, previously known as Prima BioMed Ltd, is incorporated in Australia and operates in the pharmaceutical preparations sector. Its principal executive offices are located at Level 32, Australia Square, 264 George Street, Sydney NSW 2000, Australia.

Why It Matters

This filing indicates IMMUTEP Ltd is providing updated information to the SEC, which is crucial for investors to stay informed about the company's status and regulatory compliance.

Risk Assessment

Risk Level: low — This filing is a routine disclosure (Form 6-K) and does not appear to contain significant new financial or operational information that would immediately impact risk.

Key Players & Entities

  • IMMUTEP Ltd (company) — Registrant
  • Prima BioMed Ltd (company) — Former company name
  • May 15, 2024 (date) — Filing date
  • 001-35428 (other) — SEC File Number

FAQ

What is the purpose of a Form 6-K filing?

A Form 6-K is a report of foreign private issuers that are required to furnish information which it makes or is required to make public pursuant to the laws of its home country or jurisdiction of incorporation, or which it furnishes or makes public to its security holders.

When was IMMUTEP Ltd previously known as?

IMMUTEP Ltd was formerly known as Prima BioMed Ltd, with a date of name change on November 19, 2010.

What is IMMUTEP Ltd's primary business sector?

IMMUTEP Ltd operates in the Pharmaceutical Preparations sector, with a Standard Industrial Classification code of 2834.

Where are IMMUTEP Ltd's principal executive offices located?

IMMUTEP Ltd's principal executive offices are located at Level 32, Australia Square, 264 George Street, Sydney NSW 2000, Australia.

Does IMMUTEP Ltd file annual reports under Form 20-F or 40-F?

Yes, IMMUTEP Ltd indicates it files annual reports under cover of Form 20-F.

Filing Stats: 259 words · 1 min read · ~1 pages · Grade level 16.8 · Accepted 2024-05-15 21:15:57

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Dated: May 15, 2024 IMMUTEP LIMITED By: /s/ Marc Voigt Name: Marc Voigt Title: Chief Executive Officer

View Full Filing

View this 6-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.